1-231040123-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_198552.3(FAM89A):c.89G>A(p.Ser30Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000403 in 1,240,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S30G) has been classified as Uncertain significance.
Frequency
Consequence
NM_198552.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM89A | NM_198552.3 | c.89G>A | p.Ser30Asn | missense_variant | 1/2 | ENST00000366654.5 | NP_940954.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM89A | ENST00000366654.5 | c.89G>A | p.Ser30Asn | missense_variant | 1/2 | 1 | NM_198552.3 | ENSP00000355614.4 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.0000234 AC: 2AN: 85640Hom.: 0 AF XY: 0.0000203 AC XY: 1AN XY: 49344
GnomAD4 exome AF: 0.00000403 AC: 5AN: 1240878Hom.: 0 Cov.: 31 AF XY: 0.00000164 AC XY: 1AN XY: 610250
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2023 | The c.89G>A (p.S30N) alteration is located in exon 1 (coding exon 1) of the FAM89A gene. This alteration results from a G to A substitution at nucleotide position 89, causing the serine (S) at amino acid position 30 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at